Indy Hematology Review
M

Emerging and Current Treatment of Amyloidosis and Waldenstrom’s Macroglobulinemia

By Indy Hematology Review FEATURING Morie Gertz
By Indy Hematology Review FEATURING Morie Gertz
191 views
April 20, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Related Content

AUTOPLAY
13:43
Houston Methodist Hospital

Lung Involvement in Amyloidosis

Feat. H. Huang
08:18
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Treatment Strategies for Hematocrit Control…

Feat. A. Zhou
04:15
Indy Hematology Review

Indy Hematology Review 2023: Plasma Cell Neoplasms and Amyloidosis U…

Feat. M. Gertz
09:27
ASH 2022 Conference Coverage

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

Feat. M. McMullin
17:21
Daniel Addison

Cardiovascular Considerations With (Contemporary) BTKi in the Treatm…

10:25
Morie Gertz

"You Have AL-Amyloidosis": Counseling Newly Diagnosed Pati…

16:25
Northwestern Medicine Oncology and Hematology

Diagnosis and Goals of Therapy in PV

Feat. B. Stein
19:39
Yale Cancer Center

AL Amyloidosis Treatment Updates

Feat. T. Parker
24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
21:03
Yale Cancer Center

Renal AL Amyloid

Feat. R. Luciano
10:49
Monia Marchetti

Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…

27:05
American Society of Nuclear Cardiology

Interpreting a PYP Study for TTR Cardiac Amyloid

Feat. P. Soman, M. Harinstein, S. Divakaran
10:06
ASCO 2022 Conference Coverage

ASCO 2022 Bendamustine Rituximab vs. Ibrutinib as Primary Therapy fo…

Feat. J. Abeykoon
27:26
Houston Methodist Hospital

FDA Perspective on New Therapies for Amyloidosis

Feat. R. Adigun
13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter
19:10
Houston Methodist Hospital

Amyloidosis: Pathophysiology

Feat. S. Ganguly
30:34
Houston Methodist Hospital

Current Treatment Options for AL Amyloidosis

Feat. K. Baker
12:03
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Daratumumab Monotherapy in Newly Diagnosed …

Feat. E. Kastritis
10:32
Penn Medicine Abramson Cancer Center

Penn Medicine Updates From Recent Meetings in Hematologic Malignanci…

Feat. A. Garfall
08:19
ASH 2022 Conference Coverage

ASH 2022 Results From the Phase 1/2 BRUIN Study: Safety & Tolera…

Feat. N. Shah